<DOC>
	<DOC>NCT00345748</DOC>
	<brief_summary>The purpose of this study is to demonstrate that Abatacept combined with Methotrexate will demonstrate a dose response efficacy in Japanese subjects with active Rheumatoid Arthritis similar to the dose response efficacy previously observed in the International clinical trials.</brief_summary>
	<brief_title>A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>patients with active Rheumatoid Arthritis while on methotrexate having 12 tender and 10 swollen joints at randomization no current infection or other evolutive or uncontrolled disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>